Nineteen-year Google veteran Sissie Hsiao, who led its consumer AI apps such as its chatbot Gemini, has stepped down and will ...
This week reminded us that different startups share a different approach to news: Some choose to remain quiet for a very long time, even about their acquisition details. Corporate espionage: After ...
After a few years of booming interest in AI platforms, the rubber has hit the road. Now, the market is watching closely to ...
More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Dealbreaker on MSN6d
An AI Biotech Hauls In $600M
Isomorphic Labs’ financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector.
OpenAI’s latest image update to ChatGPT isn’t just a boon for Studio Ghibli fans. It’s also a gift to businesses of all sizes ...
As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...
Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
Before today’s main column about the AI attention war between OpenAI and Google, there’s OpenAI news from my colleague ...
UK-based AI-first development company Isomorphic Labs revealed that it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation ...